You have 9 free searches left this month | for more free features.

Condition

Acute Myeloid Leukemia (1)

Allogeneic Stem Cell Transplantation (1)

Hepatic Impairment (1)

Myelofibrosis (1)

Overall Status

Recruiting (2)

Suspended (1)

Sign in for free

Phase

phase 1/phase 2 (2)

phase 1 (1)

Sponsor

Novartis Pharmaceuticals (3)

Collaborator

Intervention

siremadlin (3)

crizanlizumab (1)

ltt462 (1)

nis793 (1)

ruxolitinib (1)

sabatolimab (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

siremadlin

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Hepatic Impairment Trial in Miami, Orlando, San Antonio (Siremadlin)

Recruiting

Hepatic Impairment

Siremadlin

Miami, Florida
+2 more

Jan 18, 2023

Acute Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial (Siremadlin)

Recruiting

Acute Myeloid Leukemia
Allogeneic Stem Cell Transplantation

Siremadlin

Tel Aviv, Israel
+2 more

Jan 23, 2023

Myelofibrosis Trial in Worldwide (Ruxolitinib, Siremadlin, Crizanlizumab)

Suspended

Myelofibrosis

Ruxolitinib
+5 more

Adelaide, South Australia, Australia
+37 more

Aug 18, 2022